Jushi Holdings Reports Q3 2025 Financial Results
LOS ANGELES – Jushi Holdings Inc., a vertically integrated Cannabis operator with footprints in six states, disclosed third-quarter 2025 financials that showed revenue climbing 6.6% year-over-year to $65.7 million, driven by higher wholesales and customer ...
Compass Pathways Advances Psilocybin Therapy Timeline for Depression Treatment
LONDON & NEW YORK – Compass Pathways reported Q3 2025 financial results and signaled a faster path to market for its lead psilocybin-based therapy in treatment-resistant depression (TRD). The biotechnology firm now targets commercialization readiness ...
Missouri Trade Group Report Finds 96% of Tested Hemp Products Exceed THC Thresholds
KANSAS CITY – A new investigation by the Missouri Cannabis Trade Association (MoCannTrade) has concluded that nearly all hemp-derived products sold at unregulated retailers in the state contain illegal levels of THC, raising questions about ...
Australian Cannabis Prices Drop to New Lows, Pressuring Domestic Producers
MELBOURNE – Medicinal Cannabis flower prices in Australia have fallen to a minimum of $3.30 per gram at the patient level, a development that has intensified debates over the viability of the country's homegrown industry. ...
Google Launches Limited Test of Cannabis Advertising on Its Search Platform in Canada
TORONTO – Google has started a restricted trial allowing select Canadian Cannabis companies to place ads on its search engine, marking a cautious step toward easing long-standing prohibitions on such promotions. The initiative, which went ...
Ricky Williams Urges Trump to Advance Cannabis Rescheduling Despite Policy Pushback
WASHINGTON – Retired NFL player Ricky Williams has renewed calls for President Trump to reclassify Cannabis to Schedule III, positioning the change as vital for medical access and economic stability in an op-ed that highlights ...
Cannabis Stocks Climb 79% in a Month, But Path to Past Highs Remains Uncertain
LOS ANGELES – Publicly traded Cannabis companies have seen sharp gains recently, with the AdvisorShares Pure US Cannabis ETF (MSOS) climbing about 79% over the past month. This rally prompts questions about sustainability and potential ...
Bioxyne Reports Record Revenue, Yet Cash Outflows Climb on Expansion Push
SYDNEY – Bioxyne Limited, an Australian life sciences and wellness products company, posted its highest quarterly revenue on record for the period ended September 30, with sales reaching A$14.1 million, a 210% jump from the ...
Kansas Poll Shows Broad Support for Cannabis Reform
TOPEKA – A recent survey of Kansas residents highlights growing public enthusiasm for Cannabis policy changes, with nearly seven in ten adults endorsing medical use and close to six in ten favoring recreational access. A ...
Cybin Raises $175M in Direct Offering, Reinforcing Psychedelic Pipeline
TORONTO – Cybin Inc., a clinical-stage biopharmaceutical company focused on psychedelic-based treatments for mental health disorders, disclosed a $175 million registered direct offering, drawing commitments from a roster of established biotech investors. The deal, priced ...
